Insurance Brokerage

IN RE: Insurance Brokerage Antitrust Litigation reached the JPML more than two decades ago, and the docket now carries a single pair of pending actions — a footprint that tells its own story. This is a mature, largely wound-down matter rather than an active claims pipeline. The underlying allegations centered on contingent-commission arrangements and bid-rigging among commercial insurance brokers and carriers, conduct alleged to have inflated the cost of placed insurance for corporate and institutional buyers. Whatever claim value existed in the core conspiracy theory was resolved, litigated, or dismissed years ago; what remains is residual docket activity rather than a fresh inventory of unresolved claims.

For a funder or capital desk, a docket at this stage offers little in the way of forward-looking opportunity. There is no meaningful claim book to underwrite, no bellwether pipeline generating fresh pricing signals, and no settlement fund in active distribution that would support fee or expense advances against near-term payouts. Firms holding tail exposure connected to this docket — a handful of remaining plaintiffs, appellate contingencies, or fee disputes tied to older settlement distributions — are the more realistic capital conversation, and that is a narrower, bespoke commercial litigation finance question rather than a portfolio play.

Where Insurance Brokerage still matters commercially is as a reference point: a two-decade lifecycle from centralization to near-dormancy is a useful duration benchmark for funders pricing newer antitrust dockets against a realistic worst case. Criterica Capital's commercial litigation finance desk treats aged, low-activity dockets like this one primarily as underwriting context for current deals rather than as an active funding target — the live diligence question here is closure timing and any residual claim value, not fresh capital deployment.

A structure and litigation brief on this docket, covering its remaining claim population and procedural posture in more depth, is also available for firms doing tail diligence.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.